FDA Maryland campus' environmental impact will be topic of Feb. 2 public meeting.
This article was originally published in The Gray Sheet
Executive Summary
FDA MARYLAND CAMPUS' ENVIRONMENTAL IMPACT on Montgomery County will be discussed at a Feb. 2 public meeting headed by General Services Administration Development Director Jag Bhargava and FDA Deputy Commissioner for External Affairs Sharon Smith Holston. The meeting will be held at Gaithersburg High School, in Maryland, at 7:30 p.m. The government agencies expect the final environmental impact statement to be issued in late April or in May.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.